NVO

Novo-Nordisk A/S

D
NVO
USD
0.33
(0.2415%)
Market Closed
116,140.00
Volume
22.755
EPS
1.06
Div Yield
45.961
P/E
609,875,783,672.00
Market Cap
Today
0.2415%
1 Week
4.405%
1 Month
2.560%
6 Months
2.637%
12 Months
42.242%
Year To Date
32.412%
All Time
558.891%

Title:
Novo/Nordisk A/S

Sector:
Healthcare
Industry:
Biotechnology
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Do you need help or have a question?